Washington HB 1665: Allowing pharmacists to treat certain conditions.

Status: By resolution, reintroduced and retained in present status. (as of 2024-01-08)

State: Washington · Session: 2023-2024 · Bill: HB 1665

Sponsors: Stonier, Pollet, Santos

Bill Text

AN  ACT  Relating  to  allowing  pharmacists  to  treat  certain 1
conditions;  amending  RCW 18.64.011;  adding  a  new  section  to chapter 2
18.64 RCW; providing an effective date; and declaring an emergency.3
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:4
Sec. 1.  RCW 18.64.011 and 2021 c 78 s 1 are each amended to read 5
as follows:6
The  definitions  in  this  section  apply  throughout  this  chapter 7
unless the context clearly requires otherwise.8
(1)  "Administer"  means  the  direct  application  of  a  drug  or 9
device,  whether  by  injection,  inhalation,  ingestion,  or  any  other 10
means, to the body of a patient or research subject.11
(2)  "Business  licensing  system"  means  the  mechanism  established 12
by chapter 19.02  RCW  by  which  business  licenses,  endorsed  for 13
individual state-issued licenses, are issued and renewed utilizing a 14
business  license  application  and  a  business  license  expiration  date 15
common to each renewable license endorsement.16
(3)  "Chart  order"  means  a  lawful  order  for  a  drug  or  device 17
entered on the chart or medical record of an inpatient or resident of 18
an institutional facility by a practitioner or his or her designated 19
agent.20
H-0596.2
HOUSE BILL 1665
State of Washington68th Legislature2023 Regular Session
By Representatives Stonier, Santos, and Pollet
Read  first  time  01/30/23.     Referred  to  Committee  on  Health  Care  & 
Wellness.
p. 1HB 1665

(4)  "Closed  door  long-term  care  pharmacy"  means  a  pharmacy  that 1
provides  pharmaceutical  care  to  a  defined  and  exclusive  group  of 2
patients who have access to the services of the pharmacy because they 3
are treated by or have an affiliation with a long-term care facility 4
or  hospice  program,  and  that  is  not  a  retailer  of  goods  to  the 5
general public.6
(5) "Commission" means the pharmacy quality assurance commission.7
(6)  "Compounding"  means  the  act  of  combining  two  or  more 8
ingredients in the preparation of a prescription. Reconstitution and 9
mixing  of (a)  sterile  products  according  to  federal  food  and  drug 10
administration-approved  labeling  does  not  constitute  compounding  if 11
prepared  pursuant  to  a  prescription  and  administered  immediately  or 12
in  accordance  with  package  labeling,  and (b)  nonsterile  products 13
according  to  federal  food  and  drug  administration-approved  labeling 14
does   not   constitute   compounding   if   prepared   pursuant   to   a 15
prescription.16
(7)  "Controlled  substance"  means  a  drug  or  substance,  or  an 17
immediate precursor of such drug or substance, so designated under or 18
pursuant to the provisions of chapter 69.50 RCW.19
(8)  "Deliver"  or  "delivery"  means  the  actual,  constructive,  or 20
attempted  transfer  from  one  person  to  another  of  a  drug  or  device, 21
whether or not there is an agency relationship.22
(9) "Department" means the department of health.23
(10)  "Device"  means  instruments,  apparatus,  and  contrivances, 24
including their components, parts, and accessories, intended (a) for 25
use  in  the  diagnosis,  cure,  mitigation,  treatment,  or  prevention  of 26
disease  in  human  beings  or  other  animals,  or (b)  to  affect  the 27
structure  or  any  function  of  the  body  of  human  beings  or  other 28
animals.29
(11)  "Dispense"  means  the  interpretation  of  a  prescription  or 30
order  for  a  drug,  biological,  or  device  and,  pursuant  to  that 31
prescription or order, the proper selection, measuring, compounding, 32
labeling,  or  packaging  necessary  to  prepare  that  prescription  or 33
order for delivery.34
(12)  "Distribute"  means  the  delivery  of  a  drug  or  device  other 35
than by administering or dispensing.36
(13)  "Drug"  and  "devices"  do  not  include  surgical  or  dental 37
instruments  or  laboratory  materials,  gas  and  oxygen,  therapy 38
equipment, X-ray apparatus or therapeutic equipment, their component 39
parts  or  accessories,  or  equipment,  instruments,  apparatus,  or 40
p. 2HB 1665

contrivances  used  to  render  such  articles  effective  in  medical, 1
surgical,  or  dental  treatment,  or  for  use  or  consumption  in  or  for 2
mechanical,  industrial,  manufacturing,  or  scientific  applications  or 3
purposes. "Drug" also does not include any article or mixture covered 4
by  the  Washington  pesticide  control  act  (chapter 15.58  RCW),  as 5
enacted  or  hereafter  amended,  nor  medicated  feed  intended  for  and 6
used exclusively as a feed for animals other than human beings.7
(14) "Drugs" means:8
(a)   Articles   recognized   in   the   official   United   States 9
pharmacopoeia or the official homeopathic pharmacopoeia of the United 10
States;11
(b)  Substances  intended  for  use  in  the  diagnosis,  cure, 12
mitigation,  treatment,  or  prevention  of  disease  in  human  beings  or 13
other animals;14
(c) Substances (

View Washington HB 1665 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.